About Medibios
Medibios is a Healthcare company based in Mumbai (India) founded in 1995. Manufacturing of pharmaceuticals including cardiovascular and anti-infective drugs in India. The company has 138 employees. Its Indian entity Medibios Laboratories Limited reported revenue of ₹100 Cr. Medibios offers products and services including Cardiovascular Medicines and Antibacterials. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Medicines and Biotechnology.
Company details
Medibios Laboratories was founded in 1995 and manufacturing was initiated in 1998. Expertise in producing medicines has been developed for multinational companies such as Pfizer and Merck, with products distributed globally across various therapeutic categories. Regulatory support is provided for facilities and products in regions including Asia, Africa, Central, and Latin America. A state-of-the-art manufacturing facility is maintained in Tarapur, near Mumbai, and emphasis is placed on quality assurance and research involving over 300 formulations. Customer satisfaction is prioritized through established methodologies.
- Headquarters Mumbai, India
- Employees 138
- SectorsHealthcare
- Email••••••••
- Website medibios.in
- Legal Name Medibios Laboratories Limited
- Date of Incorporation 08 Mar, 1995
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹100 Cr
FY 2023 · -2% YoY
- Net Profit₹10.38 Cr
FY 2023 · 10% margin
- EBITDA₹20.99 Cr
FY 2023 · 21% margin
- Employee Count138
Associated legal entities of Medibios
Medibios operates through Medibios Laboratories Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medibios Laboratories Limited CIN U24230MH1995PLC086180 | Amalgamated | 08 Mar 1995 | Mumbai, Maharashtra | ₹100 Cr | 138 | 6 | View details |
Products & Services of Medibios
Medibios offers a comprehensive portfolio of products and services, including Cardiovascular Medicines and Antibacterials.
Medicines for cardiovascular conditions are manufactured and supplied globally.
Antibacterial drugs are produced for treating various infections.
Board of directors of Medibios Laboratories Limited (Medibios)
Medibios Laboratories Limited is the primary company behind Medibios. The board of Medibios Laboratories Limited currently have 5 directors; the longest-serving is Tushar Anil Korday, appointed in 2010. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tushar Anil Korday DIN 00738316 | Managing Director | 14 May 2010 | 16 yrs 5 mo | Medibios Laboratories Limited |
| Yogesh Rajendra Gole DIN 03443157 | Director | 01 Nov 2011 | 15 yrs | Medibios Laboratories Limited |
| Sharad Kantilal Sheth DIN 08090542 | Director | 20 Mar 2018 | 8 yrs 7 mo | Medibios Laboratories Limited |
| Meena Sanjiv Kapadi DIN 08074814 | Director | 20 Mar 2018 | 8 yrs 7 mo | Medibios Laboratories Limited |
| Rajendra Fattesinh Gole DIN 00738346 | Whole-time director | 20 Mar 2018 | 8 yrs 7 mo | Medibios Laboratories Limited |
Financials of Medibios
Figures of Medibios Laboratories Limited, the primary company behind Medibios, for FY 2023. Revenue was ₹100 Cr (-2% year on year). Net profit was ₹10.38 Cr (10% margin). EBITDA was ₹20.99 Cr (21% margin). Revenue has grown at a compounded annual rate of +13% over three years and +11% over five years.
- ₹100 CrRevenue · FY 2023 · -2% YoY
- ₹10.38 CrNet profit · 10% margin
- ₹20.99 CrEBITDA · 21% margin
- ₹7.10 CrPaid-up capital
- 138Employees (provident fund records)
- +13%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medibios Laboratories Limited are on its company page.
Detailed financial statements for Medibios
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medibios
Medibios was founded in 1995.
Medibios is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Medibios has 138 employees.
The primary company behind Medibios, Medibios Laboratories Limited, reported revenue of ₹100 Cr for FY 2023, down 2% year on year.
Medibios Laboratories was founded in 1995 and manufacturing was initiated in 1998. Expertise in producing medicines has been developed for multinational companies such as Pfizer and Merck, with products distributed globally across various therapeutic categories. Regulatory support is provided for facilities and products in regions including Asia, Africa, Central, and Latin America. A state-of-the-art manufacturing facility is maintained in Tarapur, near Mumbai, and emphasis is placed on quality assurance and research involving over 300 formulations. Customer satisfaction is prioritized through established methodologies.
Medibios offers Cardiovascular Medicines and Antibacterials.
Medibios operates through Medibios Laboratories Limited.
The legal entities of Medibios currently have 6 directors, including Sangeeta Amitkumar Dhanuka, Yogesh Rajendra Gole, Tushar Anil Korday and others.